ES cells) treatment significantly increases the expression of the early neuroectodermal marker Sox1 and the number of cells positive for the neural markers nestin and βIII-tubulin
519 prevented harmaline-stimulated increases in cerebellar cyclic GMP content
Smiles: CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C
with 50 nM PU-H71 needed to significantly reduce the LPS dependent nitrite release
As an agonist of the KOR
Chymostatin 4885614 ES cells) treatment significantly increasesChymostatin is a bioactive peptide of microbial origin that acts as a protease inhibitor with selectivity for chymotryptase like serine proteases. It potently inhibits chymotrypsin and chymase (Ki = 9. 36 and 13. 1 nM, respectively) while less effectively blocking the activity of cathepsins, papain, and leukocyte elastase.,,,, It is without effect on trypsin, thrombin, plasmin, pepsin, and kallikrein. Product information CAS Number: 9076 44 2